Last Updated on August 2, 2021 by The Health Master
The National Pharmaceutical Pricing Authority (NPPA) has asked the manufacturers and importers of five medical devices it has recently imposed a trade margin cap of 70 per cent to submit quarterly stock details within 10 days from the completion of the quarter, till the time the notification is in force.
The drug price regulator informed that the revised maximum retail prices of 1034 brands of medical devices has been received by the authority, from the importers and manufacturers.
In a Gazette Notification issued NPPA capped the trade margin of pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer, at 70 percent at the Price to Distributor (PTD) level.
It was notified that the prices were to be revised by the manufacturers or importers as per the formula prescribed in the notification and the revised prices and it was effective from July 20, 2021.
The quarterly stock details, including units manufactured, imported, sold and exported, have to be submitted in the prescribed format, in order to assess the availability of these devices in the country.
“…manufacturers/importers of these five medical devices are hereby directed to submit requisite quarterly stock details, for every quarter, in the prescribed format within 10 days from the completion of the quarter till the time notification mentioned above is in force,” said an NPPA notification.
In accordance with this, the new list of medical devices released by the Authority,a total of 260 pulse oximeter brands, 307 blood pressure monitoring device brands, 217 nebulisers, 150 digital thermometers, and 100 glucometer brands submitted their data including the existing and old MRP and revised MRP with effect from July 20, 2021, to the authority.